Positive FDG-PET/CT scans of a residual seminoma after chemotherapy and radiotherapy: case report and review of the literature.

Mehmet Asim Bilen, Houssam Hariri, Chady Leon, Charles C Guo, Deborah A Kuban, Louis L Pisters, Shi-Ming Tu

Journal: Clinical genitourinary cancer 2015;12(4):e147-50

PMID: 24674785

Free Full Text on PubMed Central View on PubMed

Abstract

Address: Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Hospital Medicine, Saint Joseph Mercy Hospital, Ann Arbor, MI.; Division of Hematology/Medical Oncology, Cooper Cancer Institute, Camden, NJ.; Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.; Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.; Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.; Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address: [email protected].

DOI: 10.1016/j.clgc.2014.02.006

Link outs

Free resources

Full Text Sources:

Medical:

https://medlineplus.gov/ctscans.html

Other Literature Sources:

https://scite.ai/reports/24674785

Subscription / membership required

Full Text Sources:

MeSH Terms: Adult, Chemoradiotherapy, False Positive Reactions, Fluorodeoxyglucose F18, Humans, Male, Neoplasm, Residual, Positron-Emission Tomography, Prognosis, Radiopharmaceuticals, Seminoma, Testicular Neoplasms, Tomography, X-Ray Computed